BYSI
NASDAQ
$1.24
BeyondSpring Inc (BYSI)
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $1.25 (+0.81%)
Market Cap
$52M
Free Cash Flow Yield
-36.09%
Beta (5Y)
0.69
Price Chart
Valuation
Market Cap$52M
Forward P/E10.54
P/S45.99
P/B5.38
Profitability
Gross Profit (TTM)$1.35M
EBITDA-$8.54M
EPS-$0.19
Financial Health
Free Cash Flow Yield-36.09%
Growth & Risk
Beta (5Y)0.69
Sharpe Ratio-0.40